Valentino Antonio Pironti1,2,3, Deniz Vatansever1,4,5,6, Barbara Jacquelyn Sahakian1,2,4. 1. Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge, UK. 2. Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK. 3. Suno Innova Ltd, Unit 6, 109 Cambridge Road Industrial Estate, Cambridge, UK. 4. Institute of Science and Technology for Brain-inspired Intelligence, Fudan University, Shanghai, PR China. 5. Division of Anaesthesia, School of Clinical Medicine, University of Cambridge, Cambridge, UK. 6. Department of Psychology, University of York, Heslington, York, UK.
Abstract
BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is a developmental condition that often persists into adulthood with extensive negative consequences on quality of life. Despite emerging evidence indicating the genetic basis of ADHD, investigations into the familial expression of latent neurocognitive traits remain limited. METHODS: In a group of adult ADHD probands (n = 20), their unaffected first-degree relatives (n = 20) and typically developing control participants (n = 20), we assessed endophenotypic alterations in the default mode network (DMN) connectivity during resting-state functional magnetic resonance imaging in relation to cognitive performance and clinical symptoms. In an external validation step, we also examined the dimensional nature of this neurocognitive trait in a sample of unrelated healthy young adults (n = 100) from the Human Connectome Project (HCP). RESULTS: The results illustrated reduced anti-correlations between the posterior cingulate cortex/precuneus and right middle frontal gyrus that was shared between adult ADHD probands and their first-degree relatives, but not with healthy controls. The observed connectivity alterations were linked to higher ADHD symptoms that was mediated by performance in a sustained attention task. Moreover, this brain-based neurocognitive trait dimensionally explained ADHD symptom variability in the HCP sample. CONCLUSIONS: Alterations in the default mode connectivity may represent a dimensional endophenotype of ADHD, hence a significant aspect of the neuropathophysiology of this disorder. As such, brain network organisation can potentially be employed as an important neurocognitive trait to enhance statistical power of genetic studies in ADHD and as a surrogate efficacy endpoint in the development of novel pharmaceuticals.
BACKGROUND:Attention-deficit/hyperactivity disorder (ADHD) is a developmental condition that often persists into adulthood with extensive negative consequences on quality of life. Despite emerging evidence indicating the genetic basis of ADHD, investigations into the familial expression of latent neurocognitive traits remain limited. METHODS: In a group of adult ADHD probands (n = 20), their unaffected first-degree relatives (n = 20) and typically developing control participants (n = 20), we assessed endophenotypic alterations in the default mode network (DMN) connectivity during resting-state functional magnetic resonance imaging in relation to cognitive performance and clinical symptoms. In an external validation step, we also examined the dimensional nature of this neurocognitive trait in a sample of unrelated healthy young adults (n = 100) from the Human Connectome Project (HCP). RESULTS: The results illustrated reduced anti-correlations between the posterior cingulate cortex/precuneus and right middle frontal gyrus that was shared between adult ADHD probands and their first-degree relatives, but not with healthy controls. The observed connectivity alterations were linked to higher ADHD symptoms that was mediated by performance in a sustained attention task. Moreover, this brain-based neurocognitive trait dimensionally explained ADHD symptom variability in the HCP sample. CONCLUSIONS: Alterations in the default mode connectivity may represent a dimensional endophenotype of ADHD, hence a significant aspect of the neuropathophysiology of this disorder. As such, brain network organisation can potentially be employed as an important neurocognitive trait to enhance statistical power of genetic studies in ADHD and as a surrogate efficacy endpoint in the development of novel pharmaceuticals.
Authors: G L Shulman; J A Fiez; M Corbetta; R L Buckner; F M Miezin; M E Raichle; S E Petersen Journal: J Cogn Neurosci Date: 1997 Impact factor: 3.225
Authors: Philip Shaw; Jason Lerch; Deanna Greenstein; Wendy Sharp; Liv Clasen; Alan Evans; Jay Giedd; F Xavier Castellanos; Judith Rapoport Journal: Arch Gen Psychiatry Date: 2006-05
Authors: D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar Journal: J Clin Psychiatry Date: 1998 Impact factor: 4.384
Authors: Susan Whitfield-Gabrieli; Heidi W Thermenos; Snezana Milanovic; Ming T Tsuang; Stephen V Faraone; Robert W McCarley; Martha E Shenton; Alan I Green; Alfonso Nieto-Castanon; Peter LaViolette; Joanne Wojcik; John D E Gabrieli; Larry J Seidman Journal: Proc Natl Acad Sci U S A Date: 2009-01-21 Impact factor: 11.205